BACKGROUND: Amnion-derived multipotent progenitor (AMP) cells, unlike most stem cells, have been demonstrated to be nontumorigenic and nonimmunogenic. Amnion-derived cellular cytokine solution (ACCS), a secreted product of AMP cells, is a cocktail of cytokines existing at physiological levels and has been used to accelerate epithelialization of experimental partial-thickness burns. METHODS: Using modifications of Zawacki's guinea pig partial-thickness scald burn model, a total of 65 animals were treated with ACCS, ACCS + AMP cells, unconditioned medium (UCM) + AMP cells, or either UCM alone or saline as controls. Dosage times ranged from every other day to once a week. Percent epithelialization was serially determined from acetate wound tracings. Histology was performed on wound biopsies. RESULTS: ACCS, UCM + AMP cells, and ACCS + AMP cells improved epithelialization compared with the two control groups (P < 0.05). When ACCS was delivered more frequently, statistically significant more rapid epithelialization occurred (P < 0.05). By day 7, all groups treated with ACCS had reached at least 90% epithelialization, whereas control groups were only 20-40% epithelialized (P < 0.05). Histology showed excellent regeneration of the epidermis with rete ridge formation. Hair growth occurred in ACCS-treated animals but not in the control group. CONCLUSIONS: Amnion-derived cellular cytokine solution accelerates the healing of experimental partial-thickness burns. Based on these findings, a multicenter clinical trial is underway.
BACKGROUND: Amnion-derived multipotent progenitor (AMP) cells, unlike most stem cells, have been demonstrated to be nontumorigenic and nonimmunogenic. Amnion-derived cellular cytokine solution (ACCS), a secreted product of AMP cells, is a cocktail of cytokines existing at physiological levels and has been used to accelerate epithelialization of experimental partial-thickness burns. METHODS: Using modifications of Zawacki's guinea pig partial-thickness scald burn model, a total of 65 animals were treated with ACCS, ACCS + AMP cells, unconditioned medium (UCM) + AMP cells, or either UCM alone or saline as controls. Dosage times ranged from every other day to once a week. Percent epithelialization was serially determined from acetate wound tracings. Histology was performed on wound biopsies. RESULTS:ACCS, UCM + AMP cells, and ACCS + AMP cells improved epithelialization compared with the two control groups (P < 0.05). When ACCS was delivered more frequently, statistically significant more rapid epithelialization occurred (P < 0.05). By day 7, all groups treated with ACCS had reached at least 90% epithelialization, whereas control groups were only 20-40% epithelialized (P < 0.05). Histology showed excellent regeneration of the epidermis with rete ridge formation. Hair growth occurred in ACCS-treated animals but not in the control group. CONCLUSIONS: Amnion-derived cellular cytokine solution accelerates the healing of experimental partial-thickness burns. Based on these findings, a multicenter clinical trial is underway.
Authors: S A Hammond; C Tsonis; K Sellins; K Rushlow; T Scharton-Kersten; I Colditz; G M Glenn Journal: Adv Drug Deliv Rev Date: 2000-09-15 Impact factor: 15.470
Authors: M Georgina Uberti; Francis Ko; Yvonne N Pierpont; Erika L Johnson; Terry E Wright; Charlotte A Smith; Martin C Robson; Wyatt G Payne Journal: Eplasty Date: 2009-03-25
Authors: Liyu Xing; Michael G Franz; Cynthia L Marcelo; Charlotte A Smith; Vivienne S Marshall; Martin C Robson Journal: J Burns Wounds Date: 2007-10-05
Authors: David L Steed; Cathy Trumpower; Danelle Duffy; Charlotte Smith; Vivienne Marshall; Randall Rupp; Martin Robson Journal: Eplasty Date: 2008-04-07
Authors: Michael G Franz; Wyatt G Payne; Liyu Xing; D K Naidu; R E Salas; Vivienne S Marshall; C J Trumpower; Charlotte A Smith; David L Steed; M C Robson Journal: Eplasty Date: 2008-04-11
Authors: Gabriela A Grinblat; Reas S Khan; Kimberly Dine; Howard Wessel; Larry Brown; Kenneth S Shindler Journal: Invest Ophthalmol Vis Sci Date: 2018-05-01 Impact factor: 4.799
Authors: Bennie H Jeng; Pedram Hamrah; Ziv Z Kirshner; Benjamin C Mendez; Howard C Wessel; Larry R Brown; David L Steed Journal: Transl Vis Sci Technol Date: 2022-01-03 Impact factor: 3.283
Authors: Fadi Ghieh; Rosalyn Jurjus; Amir Ibrahim; Alice Gerges Geagea; Hisham Daouk; Bassel El Baba; Sana Chams; Michel Matar; Wadih Zein; Abdo Jurjus Journal: Biomed Res Int Date: 2015-07-07 Impact factor: 3.411